Free Float 98,83 %
Shares Float 2,62 M
Shares Outstanding 2,65 M
REDWOOD PHARMA AB
Share · SE0021512134 · A403LN (XSTO)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of REDWOOD PHARMA AB
No Price
Share Float & Liquidity
Company Profile for REDWOOD PHARMA AB Share
Redwood Pharma AB engages in the development of ophthalmic pharmaceutical therapies for unmet market needs. The company's lead development product is RP101, an eye drop that treats severe chronic dry eye disease in post-menopausal women. It uses IntelliGel, a supramolecular smart drug delivery system for development of topical formulation for ophthalmic uses, as well as for administration to the front of the eye. Redwood Pharma AB is based in Stockholm, Sweden.
Company Data
Name REDWOOD PHARMA AB
Company Redwood Pharma AB
Website
https://www.redwoodpharma.se
Primary Exchange 
Frankfurt
Frankfurt
WKN A403LN
ISIN SE0021512134
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Martin Vidaeus MBA
Country Sweden
Currency EUR
Employees 0,0 T
Address Ringvagen 100E, 118 60 Stockholm
IPO Date 2016-06-15
Stock Splits
| Date | Split |
|---|---|
| 22.08.2023 | 547:500 |
| 31.10.2022 | 2921:1000 |
| 20.01.2021 | 21:20 |
| 30.08.2019 | 129:125 |
| 29.05.2017 | 271:250 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ STOCKHOLM AB | REDW.ST |
| Frankfurt | 9JV0.F |
More Shares
Investors who hold REDWOOD PHARMA AB also have the following shares in their portfolio:
